Drug Approval | June 12, 2022
Strides receives USFDA approval for Ibuprofen OTC oral suspension
Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.
Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.
During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
Co-marketing agreement between Thermo Fisher Scientific and TransMIT allows for high spatial and high mass resolution MSI platform to study complex biological tissues
The human serum-based system shows reduced interferences when testing for pyrogenicity in more complex drug products, such as in blood-derived therapeutics
Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
The proposed demerger is the most significant corporate change for GSK in the last 20 years
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Subscribe To Our Newsletter & Stay Updated
